SG Americas Securities
WHWK

SG Americas Securities’s Whitehawk Therapeutics WHWK Stock Holding History

SG Americas Securities’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-36,774
Closed -$65K – 3727
2025
Q1 		$65K Buy
+36,774
New +$96K ﹤0.01% 3178

Other funds holding WHWK

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

SG Americas Securities's WHWK Position: Q2 2025 in Review

SG Americas Securities sold out of Whitehawk Therapeutics (WHWK) in Q2 2025, closing a stake of 36,774 shares — an estimated $65K sold.

SG Americas Securities first reported a position in WHWK in Q1 2025 and held it in 1 quarter. The position peaked at $65K in Q1 2025. 39 funds tracked by Wall St. Rank hold WHWK as of Q2 2025.

  • SG Americas Securities reported no remaining Whitehawk Therapeutics position as of Q2 2025 after selling out during the quarter.
  • SG Americas Securities sold 36,774 Whitehawk Therapeutics shares in Q2 2025, an estimated $65K.
  • SG Americas Securities first reported a position in Whitehawk Therapeutics in Q1 2025 and held it in 1 quarter.
  • SG Americas Securities's Whitehawk Therapeutics position peaked at $65K in Q1 2025.
  • 39 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2025.

Based on SG Americas Securities's 13F filing for Q2 2025, filed 8 Aug 2025.